| Berkley East Healthcare Center | |
| 2021 Arizona Ave, Santa Monica, California 90404 | |
| (310) 829-5377 | |
| Name | Berkley East Healthcare Center |
|---|---|
| Location | 2021 Arizona Ave, Santa Monica, California |
| Certified By | Medicare |
| No. of Certified Beds | 207 |
| Occupancy Rate | 43.33% |
| Medicare ID (CCN) | 555748 |
| Legal Business Name | Asmb, Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1003804212 |
| Organization Name | ARIZONA & 21ST CORP |
| Doing Business As | BERKLEY EAST CONV HOSP |
| Address | 2021 Arizona Ave, Santa Monica, CA 90404 |
| Phone Number | 310-829-5377 |
News Archive
QHR Technologies Inc., a leading Canadian Healthcare technology provider announced that its Electronic Medical Records (EMR) division, Optimed Software Corporation, will connect over 700 users including 72 physicians, in the community of Barrie, Ontario to its Accuro®EMR, creating the largest integrated healthcare network in Canada using one EMR software.
Watson Pharmaceuticals, Inc. today reported net revenue grew 29 percent for the second quarter ended June 30, 2010 to $875.3 million, compared to $677.8 million in the second quarter 2009. On an adjusted cash basis, net income increased 22 percent to $102.8 million or $0.83 per share, compared to $84.2 million or $0.73 per share in the second quarter 2009. GAAP earnings for the second quarter 2010 were $0.57 per share, compared to $0.46 per share in the prior year period.
Transgenic Huntington's disease monkeys display a full spectrum of symptoms resembling the human disease, ranging from motor problems and neurodegeneration to emotional dysregulation and immune system changes, scientists at Yerkes National Primate Research Center, Emory University report.
Like a stern bodyguard for the central nervous sytem, the blood-brain barrier keeps out anything that could lead to disease and dangerous inflammation-at least when all is functioning normally.
The cover for issue 7 of Oncotarget features Figure 5, "SUM149-MA cells surviving a 6-MP treatment are sensitive to chemotherapeutic drugs," published in "Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine" by Singh, et al. which reported that the authors have reported that a lengthy treatment with low-dose 6-mercaptopurine, a clinically useful anti-inflammatory drug, inhibits such resistant cells.
› Verified 7 days ago
| NPI Number | 1952936395 |
| Organization Name | ASMB, LLC |
| Address | 2021 Arizona Ave, Santa Monica, CA 90404 |
| Phone Number | 310-829-5377 |
News Archive
QHR Technologies Inc., a leading Canadian Healthcare technology provider announced that its Electronic Medical Records (EMR) division, Optimed Software Corporation, will connect over 700 users including 72 physicians, in the community of Barrie, Ontario to its Accuro®EMR, creating the largest integrated healthcare network in Canada using one EMR software.
Watson Pharmaceuticals, Inc. today reported net revenue grew 29 percent for the second quarter ended June 30, 2010 to $875.3 million, compared to $677.8 million in the second quarter 2009. On an adjusted cash basis, net income increased 22 percent to $102.8 million or $0.83 per share, compared to $84.2 million or $0.73 per share in the second quarter 2009. GAAP earnings for the second quarter 2010 were $0.57 per share, compared to $0.46 per share in the prior year period.
Transgenic Huntington's disease monkeys display a full spectrum of symptoms resembling the human disease, ranging from motor problems and neurodegeneration to emotional dysregulation and immune system changes, scientists at Yerkes National Primate Research Center, Emory University report.
Like a stern bodyguard for the central nervous sytem, the blood-brain barrier keeps out anything that could lead to disease and dangerous inflammation-at least when all is functioning normally.
The cover for issue 7 of Oncotarget features Figure 5, "SUM149-MA cells surviving a 6-MP treatment are sensitive to chemotherapeutic drugs," published in "Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine" by Singh, et al. which reported that the authors have reported that a lengthy treatment with low-dose 6-mercaptopurine, a clinically useful anti-inflammatory drug, inhibits such resistant cells.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
QHR Technologies Inc., a leading Canadian Healthcare technology provider announced that its Electronic Medical Records (EMR) division, Optimed Software Corporation, will connect over 700 users including 72 physicians, in the community of Barrie, Ontario to its Accuro®EMR, creating the largest integrated healthcare network in Canada using one EMR software.
Watson Pharmaceuticals, Inc. today reported net revenue grew 29 percent for the second quarter ended June 30, 2010 to $875.3 million, compared to $677.8 million in the second quarter 2009. On an adjusted cash basis, net income increased 22 percent to $102.8 million or $0.83 per share, compared to $84.2 million or $0.73 per share in the second quarter 2009. GAAP earnings for the second quarter 2010 were $0.57 per share, compared to $0.46 per share in the prior year period.
Transgenic Huntington's disease monkeys display a full spectrum of symptoms resembling the human disease, ranging from motor problems and neurodegeneration to emotional dysregulation and immune system changes, scientists at Yerkes National Primate Research Center, Emory University report.
Like a stern bodyguard for the central nervous sytem, the blood-brain barrier keeps out anything that could lead to disease and dangerous inflammation-at least when all is functioning normally.
The cover for issue 7 of Oncotarget features Figure 5, "SUM149-MA cells surviving a 6-MP treatment are sensitive to chemotherapeutic drugs," published in "Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine" by Singh, et al. which reported that the authors have reported that a lengthy treatment with low-dose 6-mercaptopurine, a clinically useful anti-inflammatory drug, inhibits such resistant cells.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $7155 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 14.81 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 2.04 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 48.28 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 6.74 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.51 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.41 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.53 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 18.75 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.72 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.67 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 16.98 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.29 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.89 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.57 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 76.65 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 95.38 | 82.93 |
News Archive
QHR Technologies Inc., a leading Canadian Healthcare technology provider announced that its Electronic Medical Records (EMR) division, Optimed Software Corporation, will connect over 700 users including 72 physicians, in the community of Barrie, Ontario to its Accuro®EMR, creating the largest integrated healthcare network in Canada using one EMR software.
Watson Pharmaceuticals, Inc. today reported net revenue grew 29 percent for the second quarter ended June 30, 2010 to $875.3 million, compared to $677.8 million in the second quarter 2009. On an adjusted cash basis, net income increased 22 percent to $102.8 million or $0.83 per share, compared to $84.2 million or $0.73 per share in the second quarter 2009. GAAP earnings for the second quarter 2010 were $0.57 per share, compared to $0.46 per share in the prior year period.
Transgenic Huntington's disease monkeys display a full spectrum of symptoms resembling the human disease, ranging from motor problems and neurodegeneration to emotional dysregulation and immune system changes, scientists at Yerkes National Primate Research Center, Emory University report.
Like a stern bodyguard for the central nervous sytem, the blood-brain barrier keeps out anything that could lead to disease and dangerous inflammation-at least when all is functioning normally.
The cover for issue 7 of Oncotarget features Figure 5, "SUM149-MA cells surviving a 6-MP treatment are sensitive to chemotherapeutic drugs," published in "Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine" by Singh, et al. which reported that the authors have reported that a lengthy treatment with low-dose 6-mercaptopurine, a clinically useful anti-inflammatory drug, inhibits such resistant cells.
› Verified 7 days ago
Berkley West Healthcare Center Location: 1623 Arizona Avenue, Santa Monica, California 90404 Phone: (310) 829-4565 | |
Ocean Pointe Healthcare Center Location: 1330 17th Street, Santa Monica, California 90404 Phone: (310) 829-5411 | |
Santa Monica Health Care Center Location: 1320 20th Street, Santa Monica, California 90404 Phone: (310) 829-4301 | |
Brentwood Health Care Center Location: 1321 Franklin Street, Santa Monica, California 90404 Phone: (310) 828-5596 | |
Santa Monica Conv Ctr Ii Location: 2250 29th Street, Santa Monica, California 90405 Phone: (310) 450-7694 | |
Beachwood Post-acute & Rehab Location: 1340 15th Street, Santa Monica, California 90404 Phone: (310) 451-9706 |